Evidence map›Paper›PMID 38290043›Full record

ArticleThe Libyan journal of medicine2024

Prognostic value of the fibrinogen-to-albumin ratio (FAR) in patients with chronic heart failure across the different ejection fraction spectrum.

Sirui Yang, Jiangyuan Pi, Wenfang Ma, Wenyi Gu, Hongxing Zhang, Anyu Xu, Yanqing Liu, Tao Shi, Fazhi Yang, Lixing Chen

Open access · goldAbstract read
In one paragraph

Article in The Libyan journal of medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. A novel parameter for risk stratification in patients with takotsubo syndrome.American heart journal plus : cardiology research and practice · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sirui YangDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, China.
Jiangyuan PiGraduate School of Kunming Medical University, Kunming, China.
Wenfang MaDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, China.
Wenyi GuDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, China.
Hongxing ZhangDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, China.
Anyu XuDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, China.
Yanqing LiuDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, China.
Tao ShiDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, China.
Fazhi YangDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, China.
Lixing ChenDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, China.
First Affiliated Hospital of Kunming Medical University · CNKunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ratio of fibrinogen to albumin (FAR) is considered a new inflammatory biomarker and a predictor of cardiovascular disease risk. However, its prognostic value for patients with chronic heart failure (CHF) with different ejection fractions (EFs) remains unclear. A total of 916 hospitalized patients with CHF from January 2017 to October 2021 in the First Affiliated Hospital of Kunming Medical University were included in the study. Death occurred in 417 (45.5%) patients out of 916 patients during a median follow-up time of 750 days. Among these patients, 381 patients suffered from HFrEF (LVEF <40%) and 535 patients suffered from HFpEF or HFmrEF (HFpEF plus HFmrEF, LVEF ≥ 40%). Patients were categorized into high-level FAR (FAR-H) and low-level FAR (FAR-L) groups based on the optimal cut-off value of FAR (9.06) obtained from receiver operating characteristic (ROC) curve analysis. Upon analysing the Kaplan - Meier plots, the incidence of death was significantly higher in all patients with FAR-H and patients in both HF subgroups (

Indexed as

Heart FailureHumansIncidencePrognosisStroke Volumechronic heart failureFibrinogen/Albumin ratioinflammationmortalityprognosis

Identifiers

PMID38290043
PMCPMC10829812
OpenAlexW4391340181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.